Composition
- Active ingredients
- RIBAVIRIN 200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIBAVIRIN 40MG/ML · SolutionNDA021546-001 · Discontinued
- RIBAVIRIN 200MG **Indicated for use and comarketed with Interferon ALFA-2B, Recombinant (INTRON A), as Rebetron Combination Therapy** · CapsuleThis page
- RIBAVIRIN 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA020903-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020903.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Rebetol
- Active substance
- ribavirin
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Merck Sharp Dohme
- Status
- Discontinued
- FDA approval
- 3 Jun 1998
- Application
- NDA020903-001